Sage Journals: Discover world-class research

Abstract

The in vivo effects of Diaspirin Crosslinked Hemoglobin (DCLHb, Baxter Healthcare Corp.) on hematology and biochemistry are unknown. This study includes 6 calves (71.2±1.3 kg). In each animal a total of 2 litres of blood was exchanged for the same amount of hydroxylethyl starch (Haes, Fresenius) (n=3) or DCLHb (n=3), which is equivalent to 28cc/kg of blood substitute, over a period of 5 hours. The animals were allowed to survive 7 days. Blood samples were taken hourly during the perfusion protocol, at postoperative day (POD) 1, 2 and 7. ANOVA test was used for repeated measurements. Blood cell profiles were similar in both groups. Peak methemoglobinemia was 4.2% in the DCLHb group. Osmolarity was significantly higher in the DCLHb group with the greatest difference at POD 1 and 2. Postmortem analysis of the major organs did not show any sign of hemoglobin deposit in the DCLHb group. In the given setup DCLHb can be administered in a large quantity with good hematological tolerance and without any deposits in major organs. A prolonged plasma expander effect was observed. (Int J Artif Organs 2000; 23: 119–24)

Keywords

Hemoglobin substitute Cardiopulmonary bypass Hematology Biochemistry

Get full access to this article

View all access options for this article.

References

Starnes

J.F.

Jr. , Tewari

, Flokas

, Brown

, Van Kessel

A.L.

, Mondon

C.E.

. Effectiveness of a purified human hemoglobin as a blood substitute in the perfused rat liver. Gastroenterology 1991; 101: 1345–53.

Macdonald

V.W.

, Winslow

R.W.

. Oxygen delivery and myocardial function in rabbit hearts perfused with cell-free hemoglobin. J Appl Physiol 1992; 72, 476–83.

Hess

J.R.

, Wade

C.E.

, Winslow

R.M.

. Filtration-assisted exchange transfusion using Hb, and erythrocyte substitute. J Appl Physiol 1991; 70: 1639–44.

Przybelski

R.J.

, Malcolm

D.S.

, Burris

D.G.

, Winslow

R.M.

. Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med 1991; 117: 143–51.

Przybelski

R.J.

, Kant

G.J.

, Bounds

M.J.

, Slayter

M.V.

, Winslow

R.M.

. Rate maze performance after resuscitation with cross-linked hemoglobin. J Lab Clin Med 1990; 115: 579–88.

Malcolm

, Kissinger

, Garrioch

. Diaspirin cross-linked hemoglobin solution as a resuscitative fluid following a severe hemorrhage in the rat. Biomat Artif Cell Artif Organs 1992; 20: 495–7.

Hindman

B.L.

, Dexter

, Cutkomp

, Smith

. Diaspirin cross-linked hemoglobin does not increase brain oxygen consumption during hypothermic cardiopulmonary bypass in rabbits. Anesthesiology 1995; 83: 1302–11.

von Segesser

L.K.

, Weiss

B.M.

, Hänseler

. Improved biocompatibility of heparin surface-coated ventricular assist devices. Int J Artif Organs 1992; 15: 301–6.

Snyder

S.R.

, Welty

E.V.

, Walder

R.Y.

, Williams

L.A.

, Walder

J.A.

. HbXl99α: A hemoglobin derivative that is cross-linked between the a subunits is useful as a blood substitute. Proc Natl Acad Sci USA 1987; 84: 7280–4.

10.

Chatterjee

, Welty

E.V.

, Walder

R.Y.

. Isolation and characterization of a new hemoglobin derivative cross-linked between the αchains (Lysine 99α1-Lysine 99α2). J Biol Chem 1986; 261: 9929–37.

11.

Hess

J.R.

, Fadare

S.O.

, Tolentina

L.S.L.

, Bangal

N.R.

, Winslow

R.M.

. The intravascular persistence of cross-linked human hemoglobin. In: Brewer

, ed. Progress in clinical and biological research (vol 319). Red Cell: 7th Ann Arbor Conference. Edited by Brewer G, New York: Alan R Liss, 1989; 351–60.

12.

Peterson

K.A.

, Dewanjee

M.K.

, Kaye

M.P.

. Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1982; 84: 39–43.

13.

van Oeveren

, Kazatchkine

M.D.

, Descamps-Latscha

, Maillet

, Fischer

, Carpentier

. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg 1985; 89: 888–99.

14.

Hammerschmidt

D.E.

, Stroncek

D.F.

, Bowers

T.K.

. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 370–7.

15.

Chenoweth

D.E.

, Cooper

S.W.

, Hugli

T.E.

, Stewart

R.W.

, Blackstone

E.H.

, Kirklin

J.W.

. Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497–503.

16.

Fischer

S.R.

, Burnet

, Traber

D.L.

, Prough

D.S.

, Kramer

G.C.

. Plasma volume expansion with solutions of hemoglobin, albumin, and Ringer lactate in sheep. Am J Physiol 1999; 276: H2194–2203.

17.

De Angeles

D.A.

, Scott

A.M.

, McGrath

A.M.

. Resuscitation from hemorrhagic shock with diaspirin cross-linked hemoglobin, blood, or hetasarch. J Trauma 1997; 42: 412–14.

18.

Rea

, Bodenham

A.R.

, Mallik

, Daily

E.K.

, Przybelski

R.J.

. Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Critical Care Medicine 1997; 25: 1480–8.

19.

Baron

J.F.

, Berridge

, Brichant

J.F.

, on behalf of the DCLHb Cardiac Surgery Trial Collaborative Group. A randomized trial to assess the efficacy of diaspirin crosslinked hemoglobin (DCLHb) solution as an alternative to blood transfusion following cardiac surgery. Anesthesiology 1997; 87: A217.

20.

Swan

S.K.

, Halstenson

C.E.

, Collins

A.J.

, Colburn

W.A.

, Blue

, Przybelski

R.J.

. Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients. Am J Kidney Dis 1995; 26: 918–23.

Blood Profile during and after Hemoglobin Substitute Administration

Abstract

Keywords

Get full access to this article

References